Michael Molhoj
24Patents
5h-index
57Co-inventors
68Inventor score
Filing activity: Aug 3, 2015 → Mar 27, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9914776B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 10 | Active |
| US11286300B2 | Humanized anti-human CD19 antibodies and methods of use | Chemistry; Metallurgy | 8 | Active |
| US10941205B2 | Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use | Chemistry; Metallurgy | 8 | Active |
| US10253104B2 | Bispecific antibodies against CD3ϵ and BCMA | Chemistry; Metallurgy | 6 | Active |
| US11603411B2 | Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use | Chemistry; Metallurgy | 5 | Active |
| US10611841B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 4 | Active |
| US10611840B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 4 | Active |
| US10822402B2 | Humanized anti-tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 3 | Active |
| US9862763B2 | Humanized anti-tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10730938B2 | Bispecific antibodies and methods of use in ophthalmology | Chemistry; Metallurgy | 3 | Active |
| US11117965B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 2 | Active |
| US10538585B2 | Anti-ANG2 antibodies and methods of use | Chemistry; Metallurgy | 2 | Active |
| US11486882B2 | Method for detecting multispecific antibody light chain mispairing | Physics | 2 | Active |
| US11958912B2 | Method for determining the in vivo interaction mode | Physics | 1 | Active |
| US11787868B2 | Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
| US12030952B2 | Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
| US12287335B2 | Direct affinity measurement of human IgG1 binding multimeric antigens | Physics | 0 | Active |
| US12215152B2 | Humanized anti-human CD19 antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11952421B2 | Bispecific antibodies against CD3EPSILON and ROR1 | Chemistry; Metallurgy | 0 | Active |
| US11572404B2 | Humanized anti-Tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10766967B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 0 | Active |
| US11732036B2 | Antibody that binds to VEGF-A and ANG2 and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12297263B2 | Humanized anti-Tau(PS422) antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12358997B1 | Bispecific anti-human A-beta/anti-human transferrin receptor antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.